Azione / REGN

Bilanci e Utile di Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals Inc

Ultima chiusura
695,42 $
29/07/2026
Target price medio
n.d.
Capitalizzazione
74.736,60 $
Range 52 settimane
541,00 $ / 821,11 $

Ricavi e utile Regeneron Pharmaceuticals Inc

Bilancio annuale

AnnoRicaviUtile
202514.342,904.504,90
202414.202,004.412,60
202313.117,203.953,60
202212.172,904.338,40
202116.071,708.075,30
20208.497,103.513,20
20197.863,402.115,80
20186.710,802.444,40
20175.872,231.198,51
20164.860,43895,52
20154.103,73636,06
20142.819,56348,07
20132.104,75424,36
20121.378,48750,27
2011445,82-221,76
2010459,07-104,47
2009379,27-67,83
2008238,46-82,71
2007125,02-105,60
200663,45-102,34

Trimestrali

TrimestreRicaviUtile
4Q20214.951,702.229,00
4Q20202.236,201.149,20
3Q20222.936,201.315,70
3Q20213.452,801.632,20
3Q20202.294,00842,10
2Q20222.857,20852,10
2Q20215.138,503.098,90
2Q20201.952,00897,30
2026-03-313.605,40727,20
2025-12-313.884,30844,60
2025-09-303.754,301.460,00
2025-06-303.675,601.391,60
2025-03-313.028,70808,70
2024-12-313.789,20917,70
2024-09-303.720,701.340,60
2024-06-303.547,101.432,30
2024-03-313.145,00722,00
2023-12-313.434,301.159,60
2023-09-303.362,701.007,80
2023-06-303.158,10968,40
2023-03-313.162,10817,80
2022-12-313.414,401.197,10
2022-09-302.936,201.315,70
2022-06-302.857,20852,10
2022-03-312.965,10973,50
2021-12-314.951,702.229,00
2021-09-303.452,801.632,20
2021-06-305.138,503.098,90
2021-03-312.528,701.115,20
2020-12-312.422,901.149,20
2020-09-302.294,00842,10
2020-06-301.952,00897,30
2020-03-311.828,20624,60
2019-12-311.863,50792,00
2019-09-301.743,70669,60
2019-06-301.577,80193,10
2019-03-311.372,60461,10
2018-12-311.927,80820,40
2018-09-301.663,50594,66
2018-06-301.608,02551,41
2018-03-311.511,49477,98
2017-12-311.582,45173,52
2017-09-301.500,67388,32
2017-06-301.470,12387,74
2017-03-311.318,99248,93
2016-12-311.226,83253,12
2016-09-301.220,12264,80
2016-06-301.212,63196,22
2016-03-311.200,85165,74
2015-12-311.098,08154,99
2015-09-301.137,42210,40
2015-06-30998,62194,64
2015-03-31869,6176,02
2014-12-31802,33110,18
2014-09-30725,7979,72
2014-06-30665,7092,74
2014-03-31625,7465,44
2013-12-31610,4196,81
2013-09-30597,03141,31
2013-06-30457,6487,38
2013-03-31439,6698,87
2012-12-31414,60470,41
2012-09-30427,69191,47
2012-06-30304,4076,74
2012-03-31231,7911,65
2011-12-31122,98-53,44
2011-09-30102,83-62,37
2011-06-30107,81-62,51
2011-03-31112,20-43,45
2010-12-31133,68-14,60
2010-09-30105,98-33,88
2010-06-30115,89-25,47
2010-03-31103,53-30,52
2009-12-3196,80-36,49
2009-09-30117,46-1,02
2009-06-3090,03-14,94
2009-03-3174,98-17,48
2008-12-3155,84-31,52
2008-09-3065,58-21,12
2008-06-3060,65-18,46
2008-03-3156,38-11,62
2007-12-3164,73-13,07
2007-09-3022,31-35,84
2007-06-3022,20-26,77
2007-03-3115,79-29,92
2006-12-3110,35-30,97
2006-09-3015,62-27,41
2006-06-3019,26-23,58
2006-03-3118,22-20,38
1Q20222.965,10973,50
1Q20212.528,701.115,20
1Q20201.828,20624,60

EPS

PeriodoRealizzatoPrevisto
31/03/20269,479,12
31/12/202511,4410,83
30/09/202511,839,78
30/06/202512,898,61